As the AI era becomes increasingly shaped by foundation models, the pharmaceutical industry is entering a new phase of opportunity for discovery, design, and decision-making driven by AI for science.

A wave of AI foundation models built on plant DNA sequences is giving researchers new tools to annotate genomes, predict gene function, and measure crop traits faster than traditional methods allow.

Many businesses are just beginning to grapple with the impact of artificial intelligence, but some have been using machine learning (ML) and other emerging technologies for over a decade. Also: Most ...

While popular AI models such as ChatGPT are trained on language or photographs, new models created by researchers from the Polymathic AI collaboration are trained using real scientific datasets. The ...

Much of the data we need to revolutionize drug discovery already exists. The problem is that, often, it isn’t usable. I spent years of my graduate research building algorithms that could sift through ...

Editor’s note: This is the first story in a two-part series on the use of foundation models in the medtech industry. The second story will be published on Tuesday. More medical device companies are ...

Behavioral analysis can provide a lot of information about the health status or motivations of a living being. A new technology makes it possible for a single deep learning model to detect animal ...